Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls8_0005.txt
Subject: MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL MATERIAL
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL MATERIALS
Document Number: 1
Folder SEQ #: 27
0 Increased number of dead animals.
0 Infections and toxicoses occurring without supportive
epidemiology; e.g., tularemia occurring without a tick bite
or exposure to sick rabbits or muskrats, and Venezuelan equine
encephalitis without vectors.
e Direct evidence (i.e., finding a contaminated bomblet or
rocket from which an infections agent is isolated and
identified.)
0 witness of attack.
PROPHYLAXIS AND THERAPY
0 inanunoprophylaxis. It is anticipated that in a biological
operational situation the agents would be disseminated by aerosol
and infection would be most likely via the respiratory system,
which may be an unnatural route of infection for the agent.
Normal public health measures used to control a natural epidemic
may not be effective. Vaccines against a number of potential
biological threat agents ave been developed.
Morbidity from immunization, although generally low
can be potentially significant; this is seen more
often with relatively crude vaccine preparations
such as whole cell killed types. Idiosyncratic
reactions are associated with nearly all vaccines
but effect a very small number of recipients.
0 Chemoprophylaxis. It is impractical, wasteful and
dangerous to place everyone located in a potential target area
on prophylactic antibiotics in anticipation of a biological
attack. If an attack is known to have occurred and the
organism identified, chemoprophylaxis could be useful.
A thorough knowledge of the disease against which
protection is being sought is desirable. One should
know the appropriate antibiotic, its dosage, and
schedule of use, and the time within the incubation
period to administer the drug. For example in the
case of Q fever, the tetracycline drugs are
effective for treatment of the clinical illness.
For prophylaxis, if the drug is given in the early
incubation period, the disease will only be
suppressed, and on cessation of therapy the clinical
3
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 13 f:/Week-36/BX003203/MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL MATERIALS/medical countermeasures against biological mater:1108961508469
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL MATERIALS
Folder Seq # = 27
Subject = MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL MATER
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996